Prominent Companies in the South Korea Risperidone Market | Competitive Landscape 2026

South Korea Risperidone Market Overview

According to 6Wresearch, the South Korea risperidone market is growing rapidly, owing to the rising occurrence of mental health disorders, specifically schizophrenia and bipolar disorder, and the increased social awareness of psychiatric treatments. Risperidone is recognized as a second-generation atypical neuroleptic that balances dopamine and serotonin levels in the brain.

The growth of the market is being contributed through increased use of generic alternatives and hospital-based psychiatric care. The healthcare infrastructure is becoming more specialized, with an increasing number of mental health facilities and private clinics contributing to the expansion of the pharmaceutical supply chain for antipsychotic drugs.

Competitive Landscape

The competitive landscape of the South Korea Risperidone Industry includes local manufacturers and international pharmaceutical giants offering a variety of dosage forms, including orally disintegrating tablets, and extended-release injections. The industry leaders are actively engaged in ensuring the availability of cost-effective generics and innovative delivery systems to develop patient adherence.

Below is a list of leading players operating in the South Korea Risperidone Market:

1. Janssen Korea (Johnson & Johnson)

Janssen is the original innovator of Risperdal and remains a dominant force with its advanced delivery systems.

2. Dong-A ST Co., Ltd.

Dong-A ST is a leading domestic brand offering high-quality, affordable generic risperidone to the South Korean market.

3. Hanmi Pharmaceutical Co., Ltd.

Hanmi Pharmaceutical is a leader in the neuropsychiatry segment, providing widely prescribed risperidone brands for schizophrenia and bipolar disorder management.

4. Daewoong Pharmaceutical Co., Ltd.

Daewoong focuses on specialized therapies, maintaining a strong presence in the central nervous system market with its psychiatric portfolio.

5. Yuhan Corporation

Yuhan provides bioequivalent generic risperidone, leveraging global research to ensure high standards of efficacy and safety.

6. Chong Kun Dang Pharmaceutical Corp.

Chong Kun Dang is a key international player known for its extensive range of CNS medications, offering cost-effective psychiatric solutions.

7. HK inno. N Corporation

HK inno. N maintains a strong presence through its commitment to accessible healthcare and its portfolio of essential central nervous system treatments.

8. Boryung Pharmaceutical Co., Ltd.

Boryung Pharmaceutical is a key supplier and contract manufacturer of antipsychotic drugs, known for its excellence in producing generic psychiatric formulations.

9. JW Pharmaceutical Corporation

JW Pharmaceutical provides a diverse range of pharmaceutical solutions and specialty products that support hospital-based psychiatric care.

10. GC Biopharma (Green Cross)

GC Biopharma is a specialized player in the CNS therapeutic area, focusing on high-quality antipsychotic medications.